InvestorsHub Logo
Followers 1321
Posts 247191
Boards Moderated 52
Alias Born 12/07/2009

Re: Retire43 post# 16574

Thursday, 10/12/2017 7:51:27 AM

Thursday, October 12, 2017 7:51:27 AM

Post# of 18988
$CYCA Cytta was also drawn to CardioComm’s potential to add multiple bio-sign monitoring under their Class II medical device clearances and thereby potentially cover the EvrCare branded platform services under a SaMD classification. https://finance.yahoo.com/news/telemedicine-technology-joint-venture-announced-113000797.html


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYCA News